Introduction Opioid use disorder (OUD) contributes to high rates of maternal morbidity and mortality in the United States.1 Although treatment with buprenorphine during pregnancy is safe, effective, and reduces maternal mortality, pregnant people face barriers to treatment.2,3 Telehealth has emerged as a promising modality for delivering and increasing access to OUD care,4-6 yet outcomes for pregnant populations within dedicated telehealth settings have not been reported.
